|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| IGA Glomerulonephritis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Glomerulonephritis | |||||
| Glomerulonephritis, IGA | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Immune System Diseases | |||||
| Kidney Diseases | |||||
| Nephritis | |||||
| Urologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| omega-3 fatty acids | |||||
| prednisone | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Inflammatory Agents | |||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Hormonal | |||||
| Glucocorticoids | |||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
| Southwest Pediatric Nephrology Study Group | |||||